States can now apply for Section 1115 Medicaid waivers to conduct demonstration projects that implement innovative approaches to treating patients with substance abuse disorders. Recent guidance from the Centers for Medicare & Medicaid Services (CMS) outlines the expectations for system reform projects.
The U.S. Department of Health and Human Services (HHS) has made opioid abuse, dependence, and overdose a priority since announcing an initiative in March 2015. In addition to the opportunity for Medicaid demonstration projects, funding from the Substance Abuse and Mental Health Services Administration (SAMHSA), which is run by HHS, was recently announced, with grants of up to $33 million over 3 years for 11 states for medication-assisted treatment for substance abuse disorders. An additional $100 million in funding for medication-assisted treatment for opioid use disorder is also expected to be announced by the Health Resources and Services Administration (HRSA) in the coming days.
If you have any questions or concerns, please contact Beth Feldpush, DrPH, senior vice president of policy and advocacy, at email@example.com or 202.585.0111.